Clinical Service Center (CSC)
↗Suzhou, China
Clinical Service Center (CSC), also known as ClinService or 科林利康 (Ke Lin Li Kang), is a leading full-service Contract Research Organization (CRO) headquartered in Suzhou, China. Founded in 2009, the company provides a comprehensive suite of clinical trial services, including clinical operations, regulatory affairs, medical writing, data management, biostatistics, and pharmacovigilance. CSC is positioned as a China-based CRO with a global reach, maintaining a workforce of over 1,000 professionals across more than 12 offices in China and international branches in the US, Canada, Australia, and the Asia-Pacific region.
The company is particularly recognized for its expertise in managing trials for innovative drugs, which comprise over 90% of its project portfolio. CSC has extensive experience in high-growth therapeutic areas such as Oncology, Immunology, and Cell & Gene Therapy (CGT). It also operates Bio-link Capital, a specialized platform for biopharmaceutical asset licensing and R&D strategy, and Meta-Clinical, a dedicated data management and statistical analysis unit. CSC is a key player in harmonizing Chinese clinical research with international ICH standards.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Contract Research Organization (CRO)
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M
Founded:2009
Ownership:private
Status:operating
FUNDING
Stage:Series A/B
Total Raised:$50M+
Investors:Xieyao PE, Suzhou Industrial Investment, Jiaxing Yuhan, Suzhou Meilingge
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, mAb, ADC, Cell therapy (CAR-T), Gene therapy, RNA, Stem cell drugs
Active Trials:1000
Trial Phases:Phase 1: 300 | Phase 2: 400 | Phase 3: 250 | Phase 4: 50
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Bio-link Capital (Licensing Platform), Meta-Clinical Technology (Data Management), ClinService (Shanghai) Co., Ltd.
Key Partnerships:Bayer (Digital Clinical Service Center collaboration), Clinical Research Malaysia (CRM) - Strategic partnership for SE Asia expansion, China Pharmaceutical University (Talent cultivation and methodology research), Novonesis (Clinical study management)
COMPETITION
Position:Niche Player
Competitors:Tigermed, WuXi Clinical, ClinChoice, dMed, Parexel, IQVIA (China)
LEADERSHIP
Key Executives:
Daniel Liu - Chairman & Co-founder
Yu Xu - CEO & Founder
Hualong Sun - Chief Strategy Officer
Shuyang Xu - CFO & Board Secretary
Scientific Founders:Daniel Liu, Yu Xu, Hualong Sun
Board Members:Shuyang Xu
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Clinical Service Center (CSC). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.